BAMF Health is pioneering advancements in the field of theranostics, which integrates molecular imaging and radiopharmaceutical therapy to enhance the detection and treatment of various diseases, including cancer and neurodegenerative conditions. The center utilizes state-of-the-art imaging technologies, such as the United Imaging uEXPLORER® total-body PET/CT scanner, which boasts double the resolution and forty times the sensitivity of traditional scanners, allowing for rapid total-body scans in under five minutes. Additionally, BAMF Health employs the GE Starguide™ SPECT/CT scanner, enabling precise tumor uptake assessments shortly after therapy. The facility's unique imaging protocols, including simultaneous PET/MR and PET/CT scans, facilitate accurate diagnoses while minimizing patient exposure to additional radiation.

In its commitment to personalized medicine, BAMF Health emphasizes the development of tailored treatment plans based on individual patient responses. The center's award-winning artificial intelligence team is focused on creating algorithms that enhance diagnostic accuracy and treatment efficacy. Furthermore, BAMF Health is actively involved in clinical trials for innovative radiopharmaceutical therapies, providing patients access to cutting-edge treatments for various cancers and other serious conditions. This approach not only prioritizes patient safety and experience but also positions BAMF Health as a leader in the integration of advanced imaging and therapeutic techniques in modern healthcare.

United States

BAMF Health is the world's first vertically integrated platform for molecular imaging and radiopharmaceutical therapy. Using the most advanced imaging and therapy technologies, BAMF Health is dedicated to providing comprehensive and intelligent treatment options for patients with serious health issues such as cancer, heart disease, and stroke.

BAMF Health

Company Details